ONCOMETHYLOME
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer and for personalized treatment decisions. The company is committed to providing treating physicians with novel, accurate, and informative diagnostic tools.
ONCOMETHYLOME
Industry:
Health Diagnostics Medical
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Nginx Euro Wordpress 4.9 All In One SEO Pack NameSilo DNS
Similar Organizations
Atturos
Atturos is a clinical diagnostics company developing molecular diagnostic tests to support better patient decisions.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-08-12 | Signature Diagnostics GmbH | OncoMethylome investment in Series C - Signature Diagnostics GmbH | 5.1 M EUR |
| 2008-01-30 | Signature Diagnostics GmbH | OncoMethylome investment in Series B - Signature Diagnostics GmbH | N/A |
More informations about "OncoMethylome"
Oncomethylome.com | welcome to OncoMethylome Sciences
OncoMethylome Sciences is a bio-tech company dedicated to developing tests for early cancer detection and personalized treatment decisions. Specifically, OncoMethylome Sciences develops DNA gene methylation tests to assist physicians (i) in detecting cancer at an early stage with a …See details»
Corporate Overview - OncoMethylome
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer and for personalized treatment decisions. The company is committed to …See details»
Diagnostic Products - OncoMethylome
The World Health Organization estimates that worldwide 25 million people have cancer and that over 10 million new cases are diagnosed each year. Cancer stage at the time of detection …See details»
OncoMethylome - Crunchbase Investor Profile & Investments
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer and for personalized treatment decisions. The company is committed to …See details»
OncoMethylome Sciences - LinkedIn
OncoMethylome Sciences is a bio-tech company dedicated to developing tests for early cancer detection and personalized treatment decisions. Specifically, OncoMethylome Sciences …See details»
OncoMethylome Becomes MDxHealth, Sharpens Focus on …
Durham, NC-based OncoMethylome Sciences has changed its name to MDxHealth as part of a shift in its business strategy away from biomarker discovery and toward the development of …See details»
OncoMethylome Sciences B.V. - Amsterdam, Netherlands
Oct 8, 2010 OncoMethylome Sciences is a bio-tech company dedicated to developing tests for early cancer detection and personalized treatment decisions. Specifically, OncoMethylome …See details»
OncoMethylome - Crunchbase
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.See details»
Overview - oncomethylome.com
OncoMethylome is developing molecular diagnostic tests to assist the physician in making more informed diagnoses and treatment decisions. Specifically, OncoMethylome is developing two …See details»
OncoMethylome - Investments, Portfolio & Company Exits
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.See details»
OncoMethylome Sciences Grants Commercial License to LabCorp …
Apr 3, 2008 OncoMethylome Sciences and Laboratory Corporation of America® Holdings (LabCorp®) announced that OncoMethylome has granted LabCorp an exclusive license on …See details»
OncoMethylome grants license to LabCorp for methylation testing
OncoMethylome Sciences has granted Laboratory Corporation of America Holdings an exclusive license on certain IP technology to perform commercial MGMT methylation laboratory testing …See details»
OMS to participate in an international clinic | EurekAlert!
[email protected]. European Organization for Research and Treatment of Cancer (Belgium) Denis Lacombe Tel. +32-2-774-1635 [email protected].See details»
Company Locations - oncomethylome.com
US Office OncoMethylome Sciences, Inc. 2505 Meridian Parkway Suite 310 Durham, NC 27713 USA T: +1 919-281-0980 F: +1 919-281-0981 Click here for routeSee details»
OncoMethylome: Drug pipelines, Patents, Clinical trials - Synapse
Explore OncoMethylome with its drug pipeline, therapeutic area, technology platform, .See details»
MGMT Gene Silencing and Benefit from Temozolomide in …
Mar 10, 2005 The MGMT promoter was methylated in 45 percent of 206 assessable cases. Irrespective of treatment, MGMT promoter methylation was an independent favorable …See details»
Scientific Advisors - oncomethylome.com
Currently, Dr. Ponder is serving as the Chairman of the Scientific Advisory Board for OncoMethylome Sciences. Stephen B. Baylin, M.D. Dr. Baylin is the Virginia and D.K. Ludwig …See details»
MDxHealth - Crunchbase Company Profile & Funding
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.See details»
Epigenomics and Ovarian Carcinoma - Taylor & Francis Online
Aug 11, 2010 MO Hoque is a paid consultant to Oncomethylome Sciences, SA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a …See details»
Contact Us - oncomethylome.com
OncoMethylome Sciences continually seeks talented people to join our dynamic, international and entrepreneurial team. For career inquiries, please send your CV and motivation letter to [email …See details»